secwatch.observer — SEC 8-K summary
======================================

Issuer:     Biofrontera Inc. (BFRI)
CIK:        0001858685
Form:       8-K
Filed at:   2025-05-14T23:59:59+00:00
Accession:  0001641172-25-010330
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Biofrontera receives Nasdaq bid price deficiency notice, 180 days to cure
-------------------------------------------------------------------------

- Nasdaq notified Biofrontera on May 8, 2025 that common stock bid price closed below $1.00 for 33 consecutive business days.
- Company has until November 5, 2025 to regain compliance by closing at $1.00+ for 10 consecutive business days.
- If not compliant by deadline, company may seek additional time via reverse stock split or face potential delisting.
- Management will monitor bid price and consider available options; no assurance of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858685/000164117225010330/0001641172-25-010330-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858685/000164117225010330/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-010330

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer